0001123292-16-002938.txt : 20161103
0001123292-16-002938.hdr.sgml : 20161103
20161103160900
ACCESSION NUMBER: 0001123292-16-002938
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140312
FILED AS OF DATE: 20161103
DATE AS OF CHANGE: 20161103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHURCHILL WINSTON J
CENTRAL INDEX KEY: 0000923792
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 161971650
MAIL ADDRESS:
STREET 1: C/O SCP PARTNERS
STREET 2: SUITE 300, 1200 LIBERTY RIDGE DRIVE
CITY: WAYNE
STATE: PA
ZIP: 19087
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2014-03-12
2014-03-13
0001588972
Recro Pharma, Inc.
REPH
0000923792
CHURCHILL WINSTON J
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Common Stock
0
D
Stock Option (right to buy)
8.00
2024-03-12
Common Stock
20000
20000
D
On March 13, 2014, the reporting person filed a Form 4 mistakenly reporting (i) indirect beneficial ownership for 3,167,286 shares of common stock acquired in the conversion of Series A Redeemable Convertible Preferred Stock and 8% Convertible Promissory Notes and (ii) direct beneficial ownership of derivative securities from Series A Redeemable Convertible Preferred Stock and 8% Convertible Promissory Notes, which would convert into 1,121,548 and 2,045,738 shares of common stock, respectively, and were held by partnerships. As of March 13, 2014, the reporting person did not have indirect beneficial ownership of such shares, which were owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P. As of March 13, 2014, the reporting person only beneficially owned the stock option set forth in Table II above.
The option vests in three equal installments on March 12, 2015, 2016, and 2017.
/s/ Donna Nichols, Attorney-in-fact
2016-11-03